Aggarwal M, Puri V, Puri S. Effects of estrogen on the serotonergic system and calcitonin gene-related peptide in trigeminal ganglia of rats. Ann Neurosci. 2012;19(4):151–7. https://doi.org/10.5214/ans.0972.7531.190403.

Article  CAS  PubMed  Google Scholar 

Aggarwal M, Puri V, Puri S. Serotonin and CGRP in migraine. Ann Neurosci. 2012;19(2):88–94. https://doi.org/10.5214/ans.0972.7531.12190210.

Article  CAS  PubMed  Google Scholar 

Aloisi AM. Gonadal hormones and sex differences in pain reactivity. Clin J Pain. 2003;19(3):168–74.

Article  PubMed  Google Scholar 

Andreou AP, Edvinsson L. Mechanisms of migraine as a chronic evolutive condition. J Headache Pain. 2019;20(1):117. https://doi.org/10.1186/s10194-019-1066-0.

Article  PubMed  Google Scholar 

Berman NE, Puri V, Chandrala S, Puri S, Macgregor R, Liverman CS, Klein RM. Serotonin in trigeminal ganglia of female rodents: relevance to menstrual migraine. Headache. 2006;46(8):1230–45. https://doi.org/10.1111/j.1526-4610.2006.00528.x.

Article  PubMed  Google Scholar 

Bethea CL, Lu NZ, Gundlah C, Streicher JM. Diverse actions of ovarian steroids in the serotonin neural system. Front Neuroendocrinol. 2002;23(1):41–100. https://doi.org/10.1006/frne.2001.0225.

Article  CAS  PubMed  Google Scholar 

Brandes JL. The influence of estrogen on migraine: a systematic review. JAMA. 2006;295(15):1824–30. https://doi.org/10.1001/jama.295.15.1824.

Article  CAS  PubMed  Google Scholar 

Bron C, Sutherland HG, Griffiths LR. Exploring the hereditary nature of migraine. Neuropsychiatr Dis Treat. 2021;17:1183–94. https://doi.org/10.2147/NDT.S282562.

Article  PubMed  Google Scholar 

Chai NC, Peterlin BL, Calhoun AH. Migraine and estrogen. Curr Opin Neurol. 2014;27(3):315–24. https://doi.org/10.1097/WCO.0000000000000091.

Article  CAS  PubMed  Google Scholar 

Colson NJ, Lea RA, Quinlan S, Griffiths LR. No role for estrogen receptor 1 gene intron 1 Pvu II and exon 4 C325G polymorphisms in migraine susceptibility. BMC Med Genet. 2006;7:12. https://doi.org/10.1186/1471-2350-7-12.

Article  CAS  PubMed  Google Scholar 

Colson NJ, Lea RA, Quinlan S, MacMillan J, Griffiths LR. The estrogen receptor 1 G594A polymorphism is associated with migraine susceptibility in two independent case/control groups. Neurogenetics. 2004;5(2):129–33.

Article  CAS  PubMed  Google Scholar 

Corominas R, Ribases M, Cuenca-Leon E, Cormand B, Macaya A. Lack of association of hormone receptor polymorphisms with migraine. Eur J Neurol. 2009;16(3):413–5.

Article  CAS  PubMed  Google Scholar 

Coşkun S, Yücel Y, Çim A, Cengiz B, Oztuzcu S, Varol S, Özdemir HH, Uzar E. Contribution of polymorphisms in ESR1, ESR2, FSHR, CYP19A1, SHBG and NRIP1 genes to migraine susceptibility in Turkish population. J Genet. 2016;95(1):131–40.

Article  PubMed  Google Scholar 

Flores CA, Shughrue P, Petersen SL, Mokha SS. Sex-related differences in the distribution of opioid receptor-like 1 receptor mRNA and colocalization with estrogen receptor mRNA in neurons of the spinal trigeminal nucleus caudalis in the rat. Neuroscience. 2003;118(3):769–78.

Article  CAS  PubMed  Google Scholar 

Ghosh J, Joshi G, Pradhan S, Mittal B. Potential role of aromatase over estrogen receptor gene polymorphisms in migraine susceptibility: a case control study from North India. PLoS ONE. 2012;7(4):e34828.

Article  CAS  PubMed  Google Scholar 

Gordon Lan KK, DeMets DL. Discrete sequential boundaries for clinical trials. Biometrika. 1983;70(3):659–63.

Article  Google Scholar 

Hautakangas H, Winsvold BS, Ruotsalainen SE, Bjornsdottir G, Harder AVE, Kogelman LJA, Thomas LF, Noordam R, Benner C, Gormley P, Artto V, Banasik K, Bjornsdottir A, Boomsma DI, Brumpton BM, Burgdorf KS, Buring J E, Chalmer MA, de Boer I, Dichgans M, Erikstrup C, Färkkilä M, Garbrielsen ME, Ghanbari M, Hagen K, Häppölä P, Hottenga J-J, Hrafnsdottir MG, Hveem K, Johnsen MB, Kähönen M, Kristoffersen ES, Kurth T, Lehtimäki T, Lighart L, Magnusson SH, Malik R, Pedersen OB, Pelzer N, Penninx BWJ H, Ran C, Ridker PM, Rosendaal FR, Sigurdardottir GR, Skogholt AH, Sveinsson OA, Thorgeirsson TE, Ullum H, Vijfhuizen LS, Widén Elisabeth, Willems K, van Dijk I, de Boer AMJM, van den Maagdenberg A, Aromaa AC, Belin TF, Arfan Ikram M, Järvelin M-R, Raitakari OT, Terwindt GM, Kallela M, Wessman M, Olesen J, Chasman DI, Nyholt DR, Stefánsson H, Stefansson K, van den Maagdenberg AMJM, Hansen TF, Ripatti S, Zwart J-A, Palotie A, Pirinen M. Genome-wide analysis of 102,084 migraine cases identifies 123 risk loci and subtype-specific risk alleles. Nat Genet. 2022;54(2):152–60. https://doi.org/10.1038/s41588-021-00990-0.

Article  CAS  PubMed  Google Scholar 

Ishii M, Shimizu S, Sakairi Y, Nagamine A, Naito Y, Hosaka Y, Naito Y, Kurihara T, Onaya T, Oyamada H, Imagawa A, Shida K, Takahashi J, Oguchi K, Masuda Y, Hara H, Usami S, Kiuchi Y. MAOA, MTHFR, and TNF-β genes polymorphisms and personality traits in the pathogenesis of migraine. Mol Cell Biochem. 2012;363(1–2):357–66. https://doi.org/10.1007/s11010-011-1188-4.

Article  CAS  PubMed  Google Scholar 

Jasrotia R, Kumar P, Kundal BR, Langer S. Insights into the role of epigenetic mechanisms in migraine: the future perspective of disease management. Nucleus. 2021;64(3):373–82.

Article  Google Scholar 

Johannes CB, Linet MS, Stewart WF, Celentano DD, Lipton RB, Szklo M. Relationship of headache to phase of the menstrual cycle among young women: a daily diary study. Neurology. 1995;45(6):1076–82. https://doi.org/10.1212/wnl.45.6.1076.

Article  CAS  PubMed  Google Scholar 

Joshi G, Pradhan S, Mittal B. Role of the oestrogen receptor (ESR1PvuII and ESR1 325 C->G) and progesterone receptor (PROGINS) polymorphisms in genetic susceptibility to migraine in a North Indian population. Cephalalgia Int J Headache. 2009;30(3):311–20. https://doi.org/10.1111/j.1468-2982.2009.01967.x.

Article  Google Scholar 

Juhasz G, Zsombok T, Jakab B, Nemeth J, Szolcsanyi J, Bagdy G. Sumatriptan causes parallel decrease in plasma calcitonin gene-related peptide (CGRP) concentration and migraine headache during nitroglycerin induced migraine attack. Cephalalgia Int J Headache. 2005;25(3):179–83. https://doi.org/10.1111/j.1468-2982.2005.00836.x.

Article  CAS  Google Scholar 

Kaunisto MA, Kallela M, Hämäläinen E, Kilpikari R, Havanka H, Harno H, Nissilä M, Säkö E, Ilmavirta M, Liukkonen J, Teirmaa H, Törnwall O, Jussila M, Terwilliger J, Färkkilä M, Kaprio J, Palotie A, Wessman M. Testing of variants of the MTHFR and ESR1 genes in 1798 finnish individuals fails to confirm the association with migraine with aura. Cephalalgia. 2006;26(12):1462–72. https://doi.org/10.1111/j.1468-2982.2006.01228.x.

Article  CAS  PubMed  Google Scholar 

Kumar S, Raina JK, Sudershan A, Mahajan K, Jasrotia R, Maharana C, Panjalia RK, Kumar P. An association study of ESR1-XbaI and PvuII gene polymorphism in migraine susceptibility in the Jammu Region. Eur Neurol. 2023;86(1):55–62. https://doi.org/10.1159/000527271.

Article  CAS  PubMed  Google Scholar 

Li L, Liu R, Dong Z, Wang X, Yu S. Impact of ESR1 gene polymorphisms on migraine susceptibility: a meta-analysis. Medicine. 2015;94(35): e0976. https://doi.org/10.1097/MD.0000000000000976.

Article  CAS  PubMed  Google Scholar 

Lichten JB, Whitty A, Pieper D, Lichten EM. The confirmation of a biochemical marker for women’s hormonal migraine: the depo-estradiol challenge test. Headache. 1996;36(6):367–71. https://doi.org/10.1046/j.1526-4610.1996.3606367.x.

Article  CAS  PubMed  Google Scholar 

Martorell-Marugan J, Toro-Dominguez D, Alarcon-Riquelme ME, Carmona-Saez P. MetaGenyo: a web tool for meta-analysis of genetic association studies. BMC Bioinform. 2017;18(1):563. https://doi.org/10.1186/s12859-017-1990-4.

Article  CAS  Google Scholar 

Mattsson P. Hormonal factors in migraine: a population-based study of women aged 40 to 74 years. Headache J Head Face Pain. 2003;43(1):27–35.

Article  Google Scholar 

Östlund H, Keller EVA, Hurd YL. Estrogen receptor gene expression in relation to neuropsychiatric disorders. Ann N Y Acad Sci. 2003;1007(1):54–63.

Article  PubMed  Google S